Stock Market

Story: Sagimet Biosciences Prices Upsized IPO, Aims to Raise $85 Million

By Julie Binoche

1 / 1

  Introduction : Sagimet Biosciences Inc., a leading biotech company, has announced the pricing of its upsized initial public offering…

The Currency Analytics

Want the full story?